Rofecoxib, identified by CAS number 162011-90-7, is a chemical compound that has seen significant attention in both research and public health discourse. Initially developed for its anti-inflammatory and analgesic properties, it was widely used but later faced withdrawal from the market due to serious cardiovascular concerns. Understanding the properties of Rofecoxib is essential for anyone working with this compound, whether in historical research or for its potential applications in controlled laboratory settings. As a Rofecoxib supplier China, NINGBO INNO PHARMCHEM CO.,LTD. provides Rofecoxib as a white powder, characterized by its specific Rofecoxib properties and molecular formula, C17H14O4S. The Rofecoxib purity and usage guidelines are critical for researchers to follow, especially considering its history. The compound's molecular structure and formula are integral to its chemical behavior, and detailed documentation on Rofecoxib safety and side effects is paramount. The history of Rofecoxib is marked by its removal from the market, a decision driven by clinical trial data revealing an increased risk of heart attack and stroke among patients using the drug. This underscores the importance of rigorous safety protocols and a thorough understanding of Rofecoxib CAS 162011-90-7 properties for any research or experimental application. For those seeking to purchase Rofecoxib for laboratory use, it is vital to source from reputable suppliers who can provide comprehensive safety data sheets and certificates of analysis. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing high-quality materials and accurate information to support scientific endeavors. When researching Rofecoxib, consulting various sources for Rofecoxib properties and its pharmacological profile is highly recommended. Understanding the historical context and the reasons for its market withdrawal is crucial for responsible scientific practice. For those looking to buy Rofecoxib, ensuring compliance with all regulatory guidelines is a must.